Eiger BioPharmaceuticals, Inc.
TREATMENT OF HEPATITIS DELTA VIRUS INFECTION WITH INTERFERON LAMBDA
Last updated:
Abstract:
Methods of treating a hepatitis delta virus (HDV) infection in a human patient are provided. In some embodiments, the method comprising administering to the patient a therapeutically effective amount of interferon lambda for at least four weeks.
Status:
Application
Type:
Utility
Filling date:
18 Feb 2021
Issue date:
29 Jul 2021